Clinical value of Bacteroides fragilis in the treatment of reproductive tract infections during pregnancy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900022126

Enrollment

Unknown

Registered

2019-03-26

Start date

2019-04-04

Completion date

Unknown

Last updated

2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

reproductive tract infections during pregnancy

Interventions

Case Series:Use sanitary napkin with bacteroides fragilis

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: (1) Voluntary participation and signing of informed consent; (2) Aged 18-45 years, 12-36 weeks pregnant gestation week; (3) Complained of increased vaginal discharge (abnormal color, abnormal odor), genital itching, and combined with any of the following abnormalities: ? abnormal microbial detection; ? abnormal leucorrhea; ? abnormal culture of cervical secretions; ? fungal infection.

Exclusion criteria

Exclusion criteria: (1) Combining patients with heart, brain, liver, kidney and hematopoietic diseases and psychotic diseases; (2) Antibiotics have been used in the past two weeks; (3) Those who participate in other clinical trials or researchers believe that it is inappropriate to participate in the trial.

Design outcomes

Primary

Measure	Time frame
Leucorrhea routine;Bacterial culture of cervical secretions;Vaginal microbiological examination;	—

Countries

China

Contacts

Public ContactDeng Yuhong

The Second Affiliated Hospital of Guangzhou Medical University

1376708863@qq.com+86 020-24152843

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026